Determine early biomarkers involved in the progression of chronic obstructive pulmonary disease (COPD) to lung cancer

Investigator: Jenny Chang, MD

Study Coordinator: Mary Rose Silvas

Status: Open Not Enrolling

ClinicalTrials.gov Number: N/A

Phone: 713.441.1952

Protocol Number: PRO00024651

Description

The purpose of this exploratory biomarker study is to further our understanding of the role of cancer stem cells (CSCs) and other biomarkers in the progression of COPD to lung cancer by examining the CSC population and other related biomarkers, according to racial and ethnic differences. If possible, we will compare precancerous biomarkers between COPD and lung cancer patient samples to identify early markers for lung cancer development.
More to Explore